RPRX insider trading
Royalty Pharma plc
In the past 36 days, 2 insiders sold $6.3M.
Insider purchases
No open-market purchases by insiders in this period.
Insider sales
| Insider | Value | Holdings | Plan | Traded / filed |
|---|---|---|---|---|
Marshall Urist EVP, Research & Investments |
$236K 4,126 sh @ $57.10 |
−100.0% | Pre-scheduled | Oct 5, 2026 Filed Oct 5, 2026 |
Marshall Urist EVP, Research & Investments |
$239K 4,126 sh @ $57.88 |
−50.0% | Pre-scheduled | Sep 28, 2026 Filed Sep 30, 2026 |
Christopher Hite EVP & Chairman, Partnering |
$5.9M 100,000 sh @ $58.53 |
−27.0% | Pre-scheduled | Sep 22, 2026 Filed Sep 24, 2026 |